Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Discover why the divisor method is favored for benchmarks, offering continuity, fairness, and easier comparison across periods and actions.
21,989 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
The CLARITY Act faces a daunting 60-vote hurdle in the Senate, with July hearings and a looming August recess narrowi...
Leaders are navigating a three-way test: grow economies, protect energy security, and push for sustainability. This b...
A growing number of U.S. retirees are considering Oman and other Gulf states as viable paths to retire abroad, driven...
AARP launches its largest Community Challenge round yet, awarding $8.3 million to fund 750 projects that upgrade hous...
IKEA’s billionaire founder frugal habits defined a lifetime of thrift that outlasted a global empire. As markets face...
In a volatile 2026 market, a defensively positioned dividend stock offers stock ultimate dividend safety. Coca-Cola i...
Cardano shows a near-term buy signal, but traders warn the rebound could be brief as ADA tests key support amid a vol...
A retiree discovers a looming tax bill tied to a 401(k) balance left behind after a job change, highlighting a common...
Micron Technology stunned investors by guiding for a $50 billion fourth-quarter revenue, underscoring data-center dem...
A nobel laureate economist warns that anxiety about AI displacing workers risks shaping real outcomes, not just headl...
Sandisk leads the 2026 market rally, with outsized gains that eclipse every other S&P 500 stock. Analysts weigh how l...